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Antibiotic resistance is a rapidly growing concern in the global world of health care. As 
our ability to treat infectious becomes more advanced, so do the bacteria's ability to combat it. 
Currently, more research is needed to uncover how these microorganisms manage to defend 
themselves against the barrage of treatments available against them. The Gerczei lab is exploring 
one of the mechanisms of bacterial antibiotic resistance; specifically, how a noncoding RNA 
regulates the expression of the ykkCD multi-drug resistance efflux pump. This pump removes 
toxins from bacteria cells thus making the treatment with a wide array of antibiotics useless. 
Using Bacillus subtilis as a model organism, I studied how the ykkCD riboswitch recognizes the 
target antibiotic, tetracycline, using its derivatives oxycycline and anhydrotetracycline. The 
expression levels of the ykkCD subunits were analyzed using qRT-PCR technology. 
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Author's statement 
I perfonned an independent research project to detennine if tetracycline and its 
commercially available derivatives are recognized using Bacillus subtilis as my model organism. 
Each derivative adds or removes a specific functional group nonnally found in tetracycline that 
may be important for recognition. Bacillus subtilis was grown in both the presence and absence 
of tetracycline and its derivatives, oxycycline and anhydrotetracycline. In order to test if any of 
the derivatives are recognized, quantitative reverse transcriptase PCR (qRT-PCR) was utilized in 
order to evaluate mRNA levels of the ykkCD efflux pump. If a derivative induced ykkCD multi­
drug resistance (MDR) mRNA production, the functional groups altered compared to 
tetracycline are not essential for antibiotic recognition. If the mRNA is not produced or levels do 
not increase, the altered functional groups were important for recognition. The outcomes of this 
project will include a research paper and a poster presentation. 
My Honors thesis provided me with an opportunity to conduct research in an independent 
manner outside of a curriculum laboratory. It gave me insight on how to be self-sufficient in a 
lab setting, and introduce me to protocols utilized in professional, hypothesis-driven chemistry 
and biology research labs. Not only that, I used techniques I learned at Ball State University and 
apply them outside of the classroom while simultaneously learning new techniques. Exposure to 
all of these techniques prior to my entrance into today's competitive job market makes me a 
better suited candidate for graduate and professional programs. 
This project will be valuable to other biochemistry researchers at Ball State University as 
well as other members of the scientific community examining antibiotic resistance in bacteria. 
My research will provide clues on how bacteria recognize antibiotics and better understanding of 
toxin sensor expression. 
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Introduction 
History ofantibiotic resistance 
In 1928, Sir Alexander Fleming accidentally discovered a very curious phenomenon. He 
noticed that the presence of the fungus Penicillium chrysogenum growing on plates of bacteria 
left behind zones of inhibited bacterial growth. This observation led to one ofthe greatest 
medical breakthroughs of modem history. Many human diseases are caused by bacteria, and it 
was soon realized that these naturally produced compounds could be used to treat diseases like 
tuberculosis, cholera and syphilis. Antibiotics are naturally derived compounds that kill or 
inhibit the growth of microorganisms. Antibiotics exploit the difference in metabolism or protein 
synthesis between prokaryotic and eukaryotic cells. These compounds are produced by fungi and 
even some bacteria. The isolation, analysis, synthesis and even modification of these complexes 
led to the development of medicines that made the treatment of infectious diseases seemingly 
flawless. Antibiotics work through different mechanisms. Some inhibit the synthesis of bacterial 
proteins or interrupt their cell wall production. Today, medications are utilized worldwide and 
treat a myriad of diseases caused by pathogenic bacteria. 
However, as man was creating an effective means to fight against the bacteria, 
unbeknownst to them, the bacteria had an intrinsic method of fighting back. Antibiotics are 
naturally derived compounds, and as such, bacteria naturally developed the ability to resist them. 
Each time a doctor prescribes an antibiotic there is a risk that an antibiotic resistant strain of 
bacteria will emerge as a result. An antibiotic may effectively kill some of the organisms in a 
bacterial infection, but those that are resistant will continue to divide and multiply. In fact, over­
utilization of antibiotics as a treatment for many illnesses is only exacerbating the development 
of mutant resistant strains. Doctors and pharmacists have since begun to educate the public on 
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the importance of completing a regiment of antibiotics when prescribed in order to ensure the 
treatment is as effective as possible. 
Current cost and implications ofbacterial resistance 
According to the Centers for Disease Control and Prevention (CDC) in 2013, an 
estimated 2,049,442 illnesses and 23,000 deaths were caused by antibiotic resistance (l). The 
World Health Organization (WHO) reported 450,000 cases of multi-drug resistant tuberculosis 
(4). Without potent antibiotic treatment, TB kills 50% of infected individuals. Hospital-linked 
bacterial infections are caused by highly resistant strains of bacteria, such as methicillin-resistant 
STAPH (MRSA) and vancomysin-resistant enterococci (4). These two diseases are often 
contracted while individuals are patients in the hospital, often when immunity is compromised. 
Methicillin and vancomysin are among a couple of the most potent antibiotics commercially 
available. People infected with a resistant strain of MRSA are 64% more likely to die as a result 
of infection than those with a non-resistant strain. Every year in the United States, more people 
die from bacterial infections than HIV / AIDS and breast cancer combined (1). The CDC 
estimates that bacterial resistance is responsible for $45 billions of dollars in direct hospital costs 
annually (5). Antibiotic resistance is already a large issue in medicine and without proper 
attention, there is a chance that some of the world's most dangerous diseases will shortly become 
untreatable. 
Mechanisms ofantibiotic resistance 
The explosion of antibiotic resistance onto the medical scene has caused pharmaceutical 
companies reluctant to begin the search for new drugs. Research into drug development costs 
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billions of dollars and can take up-to a decade to reach trial stages. Furthennore, antibiotics are a 
short-tenn treatment, meaning that the company may not be able to earn back its investment or 
achieve a profit. In order for antibiotic research to be more effective, the resistance mechanisms 
must be better understood. Antibiotic resistance results from one of four mechanisms: 1) 
inactivation of antibiotic using enzymes that degrade antibiotics; 2) alteration of the antibiotic 
target, so it is unable to recognize the antibiotic; 3) block entry of the antibiotic into the cell and 
finally; 4) activation of effiux pumps to pump antibiotics out of the cell. The mechanisms of 
antibiotic resistance are diagrammed in Figure A. 
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Figure A. Schematic representation ofthe methods ofantibiotic resistance in bacteria. 
The numbers correspond to descriptions found within the text. 
Riboswitches 
My research focused on how the ykkCD RNA toxin sensor, which is a riboswitch, 
recognizes its target antibiotic. In a cell, infonnation travels from DNA -7 RNA -7 protein, 
following the central dogma of biology. Usually, a series of extra- and intra-cellular cascades is 
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necessary for the expression of genes within a cell. A riboswitch is an RJ\IA-dependent method 
of gene regulation. The name "riboswitch," is derived from the fact that these mRNA molecules 
are able to alternate between two conformational states in response to binding of a small ligand. 
Riboswitches are conserved across prokaryotes. Most riboswitches are located in the 5'-UTR of 
the gene they regulate and folds into complex 3D structures. The ligand of most riboswitches is 
produced by the gene that is regulated. Most known riboswitch molecules are involved in the 
regulation of metabolic genes in bacteria. If the metabolite concentration reaches a given 
threshold, it is able to bind to the riboswitch. The resulting binding leads to a conformational 
change which causes a down-regulation of the metabolite producing gene. Hence, the constant, 
appropriate concentration of the metabolite is maintained. 
There are eleven known riboswitch classes with a large variety of ligands. Ligands 
include coenzyme B12, Flavin mononucleotide, purines (adenine/guanine) S-adenylmethionine 
(SAM), amino acids, glucosamine-6-phosphate (G1cN6P) pre-Q1, cyclic-di-GMP and thiamine 
pyrophosphate that activates the TPP riboswitch in eukaryotes. Figure B provides an example of 
the diversity of riboswitches and the specificity of their respective ligands (9). 
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Figure B. Riboswitch examples and their respective ligands. There is a large diversity in the 
structure ofthese molecules and the groups that interact with them. 
8 

The ykkCD riboswitch-type sensor is an evolutionarily conserved portion of the 
messenger RNA (mRNA) that regulates the expression ofthe ykkCD multi-drug resistant (MDR) 
pump. The ykkCD pump is coded in the bacteria's DNA, in the 5' untranslated region of the 
MDR gene. Its proposed secondary structure is detailed in figure C. Found in 80% of Gram+ 
bacteria, MDR pumps are able to actively pump antibiotics out of the bacterial cell, rendering the 
antibiotic ineffective. The ykkCD toxin sensor recognizes and binds tetracycline in Bacillus 
subtilis. This binding causes a structural change that permits transcription of the ykkCD pump 
mRNA. Translation of the ykkCD MDR efflux pump mRNA forms the MDR efflux pump 
protein, and the bacterial cell is able to pump out the antibiotic and survive. It is expected that a 
similar mechanism exists in other Gram+ pathogens (9). 
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Figure C. Proposed secondary structure ofthe ykkCD riboswitch. 
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Tetracycline derivatives used in this study 
The overall purpose of this experiment is to understand how tetracycline is recognized by 
the ykkCD riboswitch. By changing the functional groups of tetracycline using commercially 
available derivatives, the functional groups important for tetracycline recognition can be 
uncovered. In this experiment, two derivatives of tetracycline were utilized. Traditionally, 
tetracycline was used for the treatment of bacterial infections like urinary tract infections and 
pneumonia. Tetracycline antibiotics work by preventing the growth and thus, spread, of infection 
and are not effective against any viral infections. The chemical structure of tetracycline is 
pictured in Figure D. Following D is Figures E and F that depict the chemical structures of the 
two derivatives used in this experiment, oxycycline and anhydrotetracycline. Upon inspection, 
all three structures contain identical functional groups along the bottom of each image. The 
major differences are seen along the tops of the pictures. Oxycycline contains an extra hydroxyl 
group on the third ring and anhydrotetracycline is missing a hydroxyl group on the second ring. 
1e Me
" /N 
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Figure D. Chemical structure ofthe antibiotic tetracycline. Differences in functional groups 
in comparison to oxycyline and anhydrotetracycline are indicated by the blue arrows. 
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Figure E. Chemical structure ofthe antibiotic oxycycline. Differences in functional groups in 
comparison to tetracycline and anhydrotetracycline are indicated by the blue arrows. 
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Figure F. Chemical structure ofthe antibiotic anhydrotetracycline. Differences in functional 
groups in comparison to tetracycline and oxycycline are indicated by the blue arrows. 
qRT-PCR technology 
Protein expression levels can be estimated by quantifying the levels ofmRNA within a 
cell. If the expression of the mRNA is increased in a cell, it is likely that the levels of protein 
expression are increased in correlation. In this experiment, our lab utilized qRT-PCR technique, 
which quantifies mRNA levels of a specific gene as opposed to amplifying DNA, which is what 
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traditional PCR technology was establish for (3). In qRT-PCR, the RT stands for reverse 
transcriptase. Reverse transcriptase, an enzyme that copies RNA into its complementary DNA 
strand. Once the cDNA has been created, traditional PCR methods amplify the gene-of-interest 
with the use of specifically designed primers. PCR follows the steps below. 
1. High temperatures separate the strands 
2. Lower temperatures allow the primers to anneal to the cDNA 
3. Optimal temperature allows for DNA polymerization 
Due to the high temperatures required for this process, DNA and RT from thermophilic 
organisms are used. Typically, DNA doubles each cycle under 100 percent efficiency and with 
40 cycles per experiment, the level of amplification is remarkable. In real-time PCR, fluorescent 
dyes are used that intercalate with DNA. Many cyclers have built-in fluorescent detectors that 
record the fluorescence of cDNA in real-time. That way, samples with more mRNA fluoresce 
and are detected earlier in amplification that those samples with less RNA, allowing for the 
quantification ofmRNA levels. 
My experiment 
I performed an independent research project to determine if tetracycline and some of its 
commercially available derivatives alter the expression of the ykkCD MDR pump using Bacillus 
subtilis as my model organism. The purpose of this study was to understand how the antibiotic 
tetracycline is recognized by the riboswitch. Each derivative adds or removes a specific 
functional group normally found in tetracycline that may be important for recognition. Bacillus 
subtilis was grown in both the presence and absence of oxycycline and anhydrotetracycline. In 
order to test if any ofthe derivatives are recognized, quantitative real-time PCR (qRT-PCR) was 
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performed in order to evaluate mRNA levels of the ykkCD efflux pump. If a derivative induced 
ykkCD MDR mRNA production, the functional groups altered compared to tetracycline are not 
essential for antibiotic recognition. If the mRNA is not produced or levels do not increase, the 
altered functional groups were important for recognition. 
Materials & Methods 
Cell growth in the presence and absence ofantibiotics 
Total mRNA was isolated from Bacillus subtilis spp. 168. Cells were streaked for 
isolation on LB agar and grown overnight in the incubator at 37°C. Time of growth did not 
exceed 20 hours. Cells were obtained from Bacillus subtdis Genetic Stock Center and streaked 
for isolation. In a sterile 250mL Erlerunyer flask, a single colony from the streak plate was 
dropped into 50mL ofLB media. Cells were shaken at 260rpm for 18-24 hours at 37°C. 
Samples of cells were then grown both in the presence and absence of the antibiotics 
oxycycline and anhydrotetracycline. 250f!L of cells from the previous growth broth growth were 
added to 25mL of autoclaved LB in a sterile flask . Stock concentration of antibiotic was diluted 
and added according to the values listed in Table 1. Table 1 lists the stock concentrations and 
sub-inhibitory concentrations (SIC) used for this experiment. Samples were grown overnight in 
the shaker at 37°C for no more than 19 hours. 
Table 1. Antibiotic stock concentrations, SIC levels and volumes used in growth/or mRNA 
isolation. 
Antibiotic Stock 
concentration 
Dilution Volume 
Oxycycline 5000 f!g/mL 1: 15 500 !lL 
Anhydrotetracycline 1000 f!g/mL 1:60 300 !lL 
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The SIC level is the antibiotic concentration that causes cells to grow at an optical density 
(OD) that is approximately half of a control culture. For the antibiotics in question, the SIC 
values were determined by growing cells overnight in varying concentrations of oxycycline and 
anhydrotetracycline. The following day, the OD values were measured at 595nm on the TECAN 
infinite F200 fluorescent plate reader OD values of 0.45-0.65 were accepted. This value provided 
the information necessary to determine how much liquid cell culture was needed for mRNA 
extraction. 
mRNA extraction 
To quantify the levels ofykkCD expression in response to the antibiotic treatment, it was 
necessary to extract the mRNA from the cultures grown. mRNA extraction aims to remove all 
other cellular components from the sample, including genomic DNA, which could interfere with 
analysis. Total mRNA extraction was performed using the Qiagen® RNeasy Mini Kit 
(catalogue #74104). The manufacturer's protocol was followed, complete with the on-column 
DNase digestion (catalogue #79254). After the final elution step, the concentration of mRNA 
extracted was determined using the ThermoScientific Nanodropl 000 spectrophotometer. Typical 
yields were between 120-500 ng/llL. 
Formaldehyde denaturing gel electrophoresis 
In order to ensure that the mRNA was of good quality, denaturing agarose gel 
electrophoresis was done. Good quality mRNA should yield two distinct bands, representing the 
l6S and 18S subunits of the cellular ribosomal RNA (rRNA). For the following protocol, lOX 
Formaldehyde (FA) gel buffer was needed. 
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Table 2. lOX FA Buffer and FA running Buffer components. 
lOX FA Buffer, pH 7 FA running buffer 
200 mM 3-(N-morpholino )propanesulfonic acid (MOPS) SO mL lOX FA Buffer 
SO mM sodium acetate 10 mL 37% formaldehyde 
10 mM EDTA 440 mL MilliQ water 
To prepare the gel , 100mL of FA running buffer was added to 1.0g Sigma agarose 
powder and that mixture was heated until boiling, which took approximately 1-2 minutes . The 
flask was allowed to cool and then SilL of ethidium bromide (EtBr) was added. The gel was 
poured into the apparatus and allowed to polymerize. 
In order to prepare the mRNA samples, 71lL of RNase-free water and 3 flL FA loading 
buffer was added to SilL mRNA samples for a total volume lSflL. The components of FA 
running buffer are as follows: 
• 80 ilL SOO mM EDT A (PH~8) 
• 720 flL 37% formaldehyde 
• 2 mL 100% glycerol 
• 3.084 mL 100% N,N-dimethyl formamide 
• 16 flL bromophenol blue (BPB) 
• 4 mL lOX FA Buffer 
• MilliQ water to 10 mL 
Samples were heated in 6SoC water bath for S minutes and cooled on ice for another 1-2 
minutes. The gel was covered in remaining FA running buffer and samples were loaded into the 
wells . Gel was run at 4SV for 1 hour and then UV imaged with Bio-Rad Gel-DocTM XR+ on the 
ethidium bromide setting. 
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Quantitative RT-PCR (qRT-PCR) 
After the cultures had been grown, the mRNA extracted and checked for quality using 
agarose gel electrophoresis, qRT-PCR was performed in order to quantify the mRNA levels of 
the ykkCD pump. The genes ykkC, ykkD and gyrase were obtained from OeneBank and placed 
into the Primer3 software at http://primer3.wi.mit.eduJ. The primers designed are seen in Table 3. 
The designed primers were obtained from Integrated DNA Technologies and the lyophilized 
samples were resuspended in RNase-free H20. 
Table 3. Primers used/or RT-PCR. 
Primer # bases Tm (OC) Sequence 5'73' 
ykkC forward 20 58.0 A TO OGG ATT OOT CGT OCT TG 
ykkC reverse 20 55.4 AAA OAC GGC ATA CAC GGT TC 
ykkD forward 20 59.7 GGC GTG CTC TTA OTC OGT GT 
ykkD reverse 20 60.5 TAA CAT OOA GCO GCA CTO CC 
gyrase forward 20 55.2 OAG AAA GCC COT T AC CAC AA 
gyrase reverse 20 55.4 CAC OTT TCC CCT OTT OAA CT 
RT-PCR was performed using the Applied Biosystems® Power SYBR® Green RNA-to-
CtTM 1 step kit (catalogue #4389986). For each primer set, a pre-mix was prepared by 
multiplying the volumes seen in Table 4 by the number of reactions for each primer. A no-
template control and an RT-control were also used to check against contamination, which could 
have included residual DNA. Each experimental tube and the No-RT mix received a volume of 
extracted RNA equal to 50ng. Table 5 details the contents of each experimental Corbett Research 
reaction tube. For each trial, tubes were prepared in duplicate, though the controls were only 
prepared once per trial. 
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Table 4. Pre-mix volumes/or one reaction tube. 
Volume (ilL) 
12.5 2X SYBR®Green Taq ReadyMix 
0.125 ilL 200 U/IlL moloney murine leukemia 
virus reverse transcriptase(M-ML V RT) 
1 ilL 100 JlM Forward primer 
1 ilL 100 11M Reverse2rimer 
0.375 ilL RNase-free water 
Table 5. Volumes and contents/or experimental and control tubes/or RT-PCR. 
Experimental tube No-template control No-RT tube 
151lL Pre-mix 15 ilL Pre-mix 12.5 ilL 2X SYBR®Green Taq 
ReadyMix 
50ng total RNA 10 ilL RN ase-free 
water 
1 ilL forward primer 
RNase-free water to 25gL - 1 ilL reverse jJrimer 
- - 50ng total RNA 
- - RNase-free water to 251lL 
Samples were then placed into the Corbett Research RotorGene RG-3000 and run under the 
following cycling conditions: 
• Reverse transcription 43°C for 30 minutes 
• Initial denaturation 95°C for 2 minutes 
• Denaturation 95°C for 15 seconds 
• Annealing 52°C for 30 seconds 
• Extension and fluorescence reading 60°C for 60 seconds 
• Melt curve ramp- 0.2°C/s from 45°C-95°C 
Samples were repeated for 40 cycles (denaturation~ extenstion) and the results were viewed 
on Quantitation mode. 
Data Analysis 
After the completion of a round of qRT-PCR, a variety of analyses were performed on 
the trials. (a) In qRT-PCR, mRNA is converted to DNA. The CT values were gathered from the 
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RotorGene. A CT value is the "cycle threshold," or more simply, the amount of cycles it takes 
for the machine to detect fluorescence. The higher the CTvalue, the lower the presence of the 
gene-of-interest in the sample. Melt temperature analysis was performed in order to identify each 
of the replicons used in the experiment. (b) 1 performed a one-way analysis of variance 
(AN OVA) for the treated versus untreated samples to determine difference in expression. (c) 
REST complete statistical analysis is a tool that takes into accounts the individual amplification 
efficiencies and changes in expression of a housekeeping gene in response to antibiotic 
treatment. 
The Relative Expression Software Tool (REST) was utilized in order to compare the 
mRNA expression levels ofykkC and ykkD in comparison to DNA gyrase, the reference gene in 
this experiment. This technique uses randomization to calculate 95% confidence intervals and p­
values and is specifically designed to be used with the RotorGene cycler. The values used in 
REST were gathered using a comparative quantitation of the amplification curve for each trial , 
providing "take-off' (TO) values and the amplification efficiency. One hundred percent 
polymerase efficiency would cause a doubling of material for each cycle. For each cycle, and 
average efficiency is calculated and reported as a value between 1 and 2. The TO and 
amplification values were to be entered into REST for each gene of interest (ykkC, ykkD and 
DNA gyrase) for both treated and untreated samples. 
Once the values have been entered, the efficiency (E) is calculated on a scale from 0-1, 
with 0 being no amplification and 1 being 100% efficiency. Then, pairs of TO values of treated 
and untreated samples were randomly paired and a concentration was calculated using the 
equation C = ETOuntreated.TOtreated. Then, a relative concentration was calculated using the equation 
RE = CGOI/Cref, where GOl stands for the gene-of-interest and ref indicates the reference 
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(housekeeping) gene. The calculation is repeated thousands of times with random pairs creating 
the range of expression values. Because of this, some values will be greater or lesser than the 
actual expression levels. The software has a built-in hypothesis test to estimate the likelihood 
that the difference between the samples is not just due to random chance. REST uses the Pair 
Wise Fixed Randomized Reallocation Test. If there is no difference in expression in the treated 
and untreated samples, the data could be exchanged and the expression ratio should not increase. 
GOI and references points are randomly exchanged between the treated and untreated groups 
thousands of times and the percent of times the expression value increases is recorded. The lower 
the frequency, the more likely that the results seen are not due to random chance and a p-value is 
calculated for this. 
Results 
SIC values 
The sub-inhibitory concentration (SIC) values were reported in Table 1 of the Methods 
section. The SIC level is the antibiotic concentration that causes cells to grow at an optical 
density (OD) that is approximately half of a control culture. For the antibiotics in question, the 
SIC values were detennined by growing cells overnight in varying concentrations of oxycyc1ine 
and anhydrotetracyc1ine. The following day, the OD values were measured at 595nm on the 
TECAN infinite F200 fluorescent plate reader OD values of 0.5-0.65 were accepted. For 
oxycycline it was 0.45 and for anhydrotetracyc1ine 0.65. Table I presents the SIC values from the 
concentrations in the medium and KD values. The KD values were detennined in vitro by a 
previous researcher in the lab, Delores James. 
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Table I. SIC and KD concentrations for the antibiotic treated samples. KD determinations 
comefrom previous research in the lab. 
Antibiotic [Antibiotic] in medium [KD] 
Oxycycline 14.4~M No binding observed 
Anhydrotetracycline 444nM 24.S±9.2nM 
Melting temperatures 
Melt curve analysis was performed in order to ensure the identity of all replicons 
produced in this experiment. The values were determined using the Rotorgene analysis to 
produce a melt curve. An example of the melt curve can be seen in Appendix C. Thresholds were 
recorded at 0.5-1.6. The primary ykkC replicon melted at 82.16°C. The primary ykkD replicon 
melted at an average temperature of 80.33°C. Finally, the gyrase replicon melted at an average 
temperature of 80.SoC. In Table IV, a comparison of expected and actual melt temperatures is 
presented for the ykkC and ykkD replicons. Based on this data, the correct replicons for each GOI 
were created from the sample mRNA. 
Table IV. Melting temperature comparison ofpredicted and actual Tmfor the replicons ofthe 
GOI. 
Replicon Predicted melting teml!JoC) Actual meltin~ temp (OC) 
ykkC 82.5 82.16 
ykkD 80.9 80.33 
Formaldehyde denaturing gel electrophoresis 
Figure I depicts the results from cell from the formaldehyde denaturing gel 
electrophoresis. For each sample, two distinct bands are present, representing the 16S and I8S 
subunits of ribosomal RNA, indicating that the total mRNA extracted is of good quality, which is 
required for qRT-peR. 
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Figure I. Gel image from formaldehyde denaturing gel electrophoresis. From left to right: 
Cntrl-control total mRNA, Oxy-oxycycline treated total mRNA and Anht-anhydrotetracycline­
treated total mRNA. 
qRT-PCR 
The results of the qRT -PCR provided information that then required further analysis. The 
CT values indicate that a particular mRNA has detectable concentrations. As a result, if an 
mRNA is present in cells at a low concentration, it takes more amplification cycles to result in 
detectable fluorescence levels. Hence, the mRNAs with low concentration have higher CT values 
than mRNAs with high concentrations. The CT values for each experimental condition are listed 
in Table II. A total of four trials were run with each sample performed in duplicates for each 
trial. An example of the fluorescence curve from the RotorGene once cycling is seen in 
Appendix A. In Appendix B, a curve of the CT determination is depicted. 
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Table II. CT values from qRT -PCR. From left to right, CC-untreated (control) ykkCprimer, 
OC-oxycycline treated ykkC primer, A C-anh ydrotetracycline treated primer. CD-untreated 
ykkD primer, OD-oxycycline treated ykkD primer, AD-anhydrotetracycline treated ykkD 
primer. CG- control gyrase, OG-oxycycline gyrase primer, A G-anhydrotetracycline treated 
primer. 
CC OC AC CD OD AD CG OG AG 
24.31 24.52 25.25 31.88 32.33 32.18 25.57 2l.63 29.93 
23.67 23.12 24.59 31.68 33.31 31.42 25.84 20.98 30.08 
24.49 23 .99 2l.0 1 30.68 31.25 30.91 26.36 22.27 36.12 
24.2 23.36 22.59 31.49 30.95 33.5 26.67 20.72 29.37 
22.95 24.22 22.61 30.3 3l.66 30.22 31.36 32.32 28.35 
23.04 23.39 22.87 30.92 31.24 30.97 25.04 2l.28 29.18 
26.61 26.62 24.23 31.5 31.45 31.63 24.33 24.67 29.02 
26.39 26.69 25 .25 30.78 32.21 31.51 25.14 20.79 29.23 
Since the CT values tell you which cycle fluorescence were first detected at, a quick 
visual inspection of the data provides a good indication as to the expression levels. For the ykkC 
pump, the untreated and treated samples do not appear to be drastically different, meaning that 
gene expression was neither significantly down- or up-regulated. In the treated and untreated 
samples ofthe ykkD pump, again there is little difference in the CT values recorded. 
Interestingly, the gyrase samples appear to be down-regulated in the anhydrotetracycline-treated 
samples. The inspection of the housekeeping CT values for the treated and untreated cells 
showed that a down-regulation of overall gene expression may have occurred. Remember, the 
higher the CT value, the lower the mRNA concentration. 
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Figure II. Bar charts ofall CTvalues collectedfrom the RotorGene analysis. (AJ The CTvalues 
ofthe control DNA gyrase samples as compared with the oxycycline and anyhydrotetracycline 
treated samples. (BJ The CT values ofthe control ykkC samples as compared with the 
oxycycline and anyhydrotetracycline treated samples. (C) The CTvalues ofthe controlykkD 
samples as compared with the oxycycline and anyhydrotetracycline treated samples. 
Analysis ofCrvalues 
A one way analysis of variance (ANOV A) with Tukey was perfonned on the CT values in 
order to see if the expression of the treated and untreated samples was statistically significant. No 
statistically significant difference between any of the treated and untreated samples was seen 
based on this analysis. Conventionally, a p-value <0.05 indicates evidence to support significant 
difference between datasets. Any p-value greater than 0.1 indicates no statistically significant to, 
and a 0.05<p<0.1 indicates that there is a statistically significant difference between datasets. 
Table V presents the p-values detennined by the ANOV A. With the ykkD pump, the oxycyc1ine­
treated versus untreated sample had a p-value between 0.05 and 0.1, which indicates some 
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evidence that the ykkD may be down-regulated in the presence of oxycycline. Further analysis 
should include changes in housekeeping gene expression. 
Table V. p-values for the treated versus the untreated samples reported by ANOVA. P-values 
further discussed are in bold. 
Gene of interest Oxycycline treated Anhydrotetracyciine treated 
ykkC 0.965 0.231 
ykkD 0.077 0.347 
DNA lV'rase 0.102 0.042 
The p-value of the anhydrotetracycline sample was <0.05, which shows a statistical 
significance when compared to the untreated sample. A down-regulation of DNA gyrase 
expression might indicate that the total mRNA levels in general were lower in the 
anhydrotetracycline samples. Taking this into consideration, no change in the ykkCD pump 
mRNA levels might mean that ykkCD expression is up-regulated in the anhydrotetracycline 
treated samples. To definitively make this conclusion about the data, it needs to be re-analyzed 
using a program that takes changes in housekeeping gene expression levels into consideration. At 
the time of this thesis, the program REST that could complete this analysis was temporarily 
unavailable. 
TO and amplification efficiency 
The TO values and amplification efficiencies from the RotorGene are detailed for each 
primer in Table VI. An example of the TO curve can be seen in Appendix D. 
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Table VI. Take-offvalues and amplification efficiencies (AE). Key for other valuesfollows 
same pattern as in Table 1. 
CG AE CC AE CD AE OG AE OC AE OD AE AG AE AC AE AD AE 
27.1 1.77 25 .6 1.78 32.9 1.82 23.1 1.74 26.6 1.75 33 .2 1.76 32.1 1.74 27 1.78 33.5 1.87 
27.4 1.77 25 .1 1.74 33 1.73 22.3 1.73 24 .9 1.78 33.7 1.92 32.1 1.75 26.5 1.72 33.2 1.8 
28.2 1.76 25.9 1.75 32.5 1.81 23 .9 1.76 25.8 1.79 33 1.81 34.2 1.48 22 .5 1.73 32.1 1.75 
28.5 1.76 25.7 1.73 32.9 1.82 22.5 1.75 25 1.75 32.2 1.75 31.1 1.75 24.1 1.73 33.5 1.87 
33.3 1.83 25.2 1.78 32.1 1.8 32.3 1.55 26.4 1.77 33.2 1.87 30.3 1.78 24.3 1.8 31.7 1.78 
27.2 1.83 25 1.78 32.8 1.86 23 1.79 25.2 1.79 32.8 1.83 31.1 1.8 24.6 1.81 32.4 1.79 
27 1.87 29.5 1.89 33.5 1.96 24.2 1.85 29.4 1.94 33 .5 1.97 31.6 1.89 26.9 1.91 33.4 1.88 
27.7 1.9 29 1.88 33 1.96 23.4 1.89 29.4 1.93 34 1.95 31.3 1.87 27.9 1.88 33.2 1.87 
REST analysis 
Due to temporary inaccessibility to the REST analytical software, REST analysis was 
unable to be performed at the time of this thesis. 
Discussion 
In this study, the recognition of two tetracycline derivatives, oxycycline and 
anhydrotetracycline, by the ylckCD riboswitch RNA toxin sensor were examined. This was 
achieved by growing Bacillus subtilis both with and without the presence of the sub-inhibitory 
concentration of antibiotic in culture medium. The total RNA was then extracted from these 
samples. In order to determine how the ylckCD pump expression was affected by the sensor, 
qRT-PCR was utilized. 
SIC value determination 
The sub-inhibitory concentration (SIC) values are the antibiotic concentrations that cause 
cells to grow at an optical density (OD) that is approximately half of a control culture. SIC 
values are not ubiquitous, and many factors have to be taken into account when utilizing them in 
research. The derivatives used in this experiment were light sensitive and stored in a 4°C freezer 
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until use. Samples were kept out of direct light as much as possible, but there is still the chance 
that environmental factors affected the effectiveness of the antibiotics in vivo. 
Formaldehyde denaturing gel electrophoresis and melting temperature 
Once the RNA had been extracted, the denaturing formaldehyde gel electrophoresis 
depicted that the RNA was of good quality to proceed with the qRT-PCR. Four trials were 
performed, and each trial had duplicates of each sample for a total of eight individual trials that 
were to be analyzed. The melting temperature analysis indicated that the ykkC and ykkD 
replicons were assumed to be the mRNA generated, as the predicted melting temperatures 
correlated with the actual observed values, as seen in Table IV of the Results section 
qRT-PCR analysis 
A quick visual interpretation of the Cr values and statistical analysis both indicated that 
there was no significant up- or down-regulation for any of the oxycycline or anhydrotetracycline 
samples when compared to the untreated samples for each individual operon. 
The Cr values from each trial were plotted on a bar chart in order to compare the 
untreated and treated samples for each gene (DNA gyrase. ykkC and ykkD), and a visual 
comparison of these charts suggested no change in gene expression. One-way ANOV A indicated 
no statistically significant difference in expression of the ykkC or the ykkD pumps due to the 
presence of these antibiotics was seen. The error bars for these samples were very small, as the 
data was of good quality. These signs all point to the fact that functional groups altered on the 
derivatives were important for recognition by the riboswitch, as the expression levels of the 
ykkCD efflux pump were unchanged. 
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Compared to the structure of tetracycline, presented in Figure D of the Introduction, 
oxycycline has an extra hydroxyl (-OH) group from the left, causing crowding in the upper 
portion of the molecule. This crowding may lead to steric clash at the active site, hence 
positioning of the oxy into the active site is prevented. Anhydrotetracycline is missing a 
hydroxyl group on the second ring of the structure. Hydroxyl groups are important hydrogen 
bond donors and acceptors, and its absence may have led to the altered binding. 
Past work from this laboratory has showed that anhydrotetracycline tightly binds to the 
riboswitch mRNA with a Ko value of 24.S±9.2nM detennined in an in vitro binding assay (7). In 
my experiment, the in vivo concentration of the anhydrotetracycline was 444nM, well above the 
Ko value. Thus, the ykkCD would be expected to be saturated at this level, and increased levels 
of ykkCD pump mRNA would be expected. However, this experiment shows that there is no 
elevation in the expression of the ykkCD MDR pump. This discrepancy is possible due to one of 
two reasons. The first discrepancy is that the cytosolic concentration of anhydrotetracycline 
might not be equal to the concentration of the antibiotic in the media. Thus, there may not be 
enough antibiotic in the cell to initiate binding and subsequent up-regulation ofykkCD pump 
gene expression. The second reason stems from the fact that the overall mRNA levels in the 
anhydrotetracycline treated samples appear to have been down-regulated based on the analysis of 
housekeeping gene expression levels of the untreated and treated samples, as seen in Figure II of 
the results section. This phenomenon requires a more careful analysis in reference to a 
housekeeping gene. It may reveal that the ykkCD pump mRNA was in fact up-regulated, but a 
program like REST is required to make that conclusion. 
For oxycycline, a preliminary trial indicated down-regulation of the pump (7). However, 
oxycycline was also shown to be non-binding, and a Ko value could not be detennined. This 
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experiment showed that there is neither up- nor -down-regulation of the pump in the presence of 
either tetracycline derivative. It is important to note that the in vivo concentration of oxycycline 
was quite high (l4.4!J.M) and still no up-regulation appeared to take place, indicating that the 
functional groups altered were probably important for ligand recognition. 
ykkCD regulation 
The ykkCD MDR efflux pump is a dimer composed of two subunits: the ykkC and the 
ykkD. Without both of these subunits, the MDR efflux pump cannot be expressed, so it was vital 
in this experiment to explore the effects of antibiotics on both subunits. What the results of this 
experiment indicate is that the expression of both the ykkC and ykkD were unaffected by the 
presence of these two derivatives, meaning that the functional groups altered were important for 
recognition. If the functional groups altered were not important changing them would have 
retained recognition of these derivatives by the ykkCD riboswitch and resulted in up-regulation 
of the pump. It is vital to note that an increase in mRNA expression correlates with increased 
protein levels in a cell. The results of this experiment will aid in the search for a method to deal 
with antibiotic resistance in bacteria. By understanding how the bacteria recognize the 
antibiotics, researchers are better able to design a drug that can evade the bacterial defense 
mechanisms. 
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Appendix 
A. An example ofthe fluorescence curve from the RotorGene once cycling was complete. The key color corresponds to the 
appropriate line on the chart. 
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B. 	An example ofthe curve used to determine the CT values. This curve was for a single trial ofPCR. The key from the Figure in 
Appendix A corresponds to this curve. 
Norm . Fluoro . 
' 
10"-0.5 
10"-1 
10"-1 .5 
10"-2 
10"-2.5 
10"-3 
o 
Threshold 	
/~ 
/,,/ 
/" /~ 
/ 1/ / 
--------
'/ , / 
35 4Cycle 
32 

O~L. • II I '41111 : ~ 
0,4 
0.2 
o 
C. An example ofthe curve used to determine the melting temperatures for the different replicons during the qRT-PCR 
experiments in the RotorGene. The key from Appendix A corresponds to this curve. 
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-0.4 
D. An example ofthe curve used to determine the TO values and amplification efficiencies. The key from Appendix A corresponds 
to this curve. 
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